Connor Clark & Lunn Investment Management Ltd. Takes Position in Bath & Body Works, Inc. (NYSE:BBWI)

Connor Clark & Lunn Investment Management Ltd. acquired a new position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) during the third quarter, HoldingsChannel.com reports. The institutional investor acquired 230,911 shares of the company’s stock, valued at approximately $7,371,000.

Other hedge funds have also recently bought and sold shares of the company. First Community Trust NA acquired a new position in Bath & Body Works during the 2nd quarter worth $30,000. Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares in the last quarter. Meeder Asset Management Inc. lifted its holdings in Bath & Body Works by 480.3% in the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,436 shares during the period. GAMMA Investing LLC lifted its holdings in Bath & Body Works by 65.4% in the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock worth $72,000 after purchasing an additional 730 shares during the period. Finally, EntryPoint Capital LLC grew its position in Bath & Body Works by 224.0% in the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock valued at $74,000 after buying an additional 1,017 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on BBWI shares. UBS Group reduced their price target on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday, August 29th. Bank of America decreased their price target on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. Wells Fargo & Company lowered their price target on Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 6th. Barclays lowered Bath & Body Works from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $31.00 to $28.00 in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. lowered their target price on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $42.25.

Read Our Latest Analysis on Bath & Body Works

Insiders Place Their Bets

In other news, CEO Gina Boswell bought 6,000 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.27% of the company’s stock.

Bath & Body Works Stock Up 0.5 %

Shares of NYSE:BBWI opened at $30.71 on Friday. The company’s fifty day moving average is $30.55 and its two-hundred day moving average is $35.99. The company has a market cap of $6.73 billion, a P/E ratio of 7.44, a price-to-earnings-growth ratio of 0.97 and a beta of 1.79. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Equities research analysts anticipate that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend is Friday, November 22nd. Bath & Body Works’s payout ratio is presently 19.37%.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.